Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immuno-LL2: Treatment With 90Y-hLL2 IgG.
Phase of Trial: Phase I/II
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Epratuzumab Y-90 (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- Sponsors Immunomedics
- 15 Jun 2009 Results have been presented at the 56th Annual Meeting of the Society of Nuclear Medicine (2009), as reported in an Immunomedics media release. Actual patient number updated (n=64).
- 17 Jan 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2007 Interim results were presented at the 12th Congress of the European Hematology Association in June 2007 (9076809).